CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Cash Flows from Operating Activities
Net income	$ 16,563	$ 7,841	$ 19,679	$ 13,633
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	38,514	34,899	76,886	69,623
Gain on disposal of property, plant and equipment	(49)	(68)	(10)	(64)
Equity-based compensation expense	1,062	1,062	2,124	2,124
Excess tax benefits from equity-based compensation	(3,160)		(3,168)
Loss on early debt extinguishment		5,172	122	5,172
Equity in earnings of unconsolidated subsidiary	(87)	(105)	(162)	(214)
Dividends received			556	611
Noncontrolling interest in earnings		130
Deferred income taxes	2,897	107	2,157	207
Payment of dissenting shareholder settlement	(13,717)		(13,717)
Changes in operating assets/liabilities, net of acquisitions:
Trade and other accounts receivable	(15,170)	(7,482)	(56,521)	(42,829)
Parts and supplies inventory	(104)	437	(154)	388
Prepaids and other current assets	(6,940)	(6,809)	(9,488)	(6,537)
Accounts payable and accrued liabilities	(13,900)	(19,844)	(1,606)	26,205
Insurance accruals	766	(2,260)	(3,452)	(5,188)
Net cash provided by operating activities	6,675	13,080	13,246	63,131
Cash Flows from Investing Activities
Purchases of property, plant and equipment	(15,705)	(12,475)	(26,198)	(25,185)
Proceeds from sale of property, plant and equipment	131	1,378	328	1,451
Acquisition of businesses, net of cash received		(300)	(1,423)	(1,300)
Net change in insurance collateral	(8,053)	53,847	(402)	108,374
Other investing activities	650	509	(52)	(2,296)
Net cash (used in) provided by investing activities	(22,977)	42,959	(27,747)	81,044
Cash Flows from Financing Activities
Envision Healthcare Corporation issuance of class A common stock	426		1,117
Borrowings under senior secured term loan facility			150,000
Repayments of senior secured term loan facility and other debt	(3,372)		(7,044)	(172,474)
Net borrowings (payments) under ABL credit facility	27,500	(168,825)	(97,500)	(172,474)
Debt issue costs	(596)		(5,007)	(95)
Repayment of equity		(130)		(130)
Excess tax benefits from equity-based compensation	3,160		3,168
Proceeds from noncontrolling interest		3,826		6,530
Dividend paid	(20,813)		(20,813)
Payment of dissenting shareholder settlement	(38,336)		(38,336)
Net change in bank overdrafts	5,234	3,927	8,117	12,169
Net cash used in financing activities	(26,797)	(161,202)	(6,298)	(154,000)
Change in cash and cash equivalents	(43,099)	(105,163)	(20,799)	(9,825)
Cash and cash equivalents, beginning of period	79,851	229,361	57,551	134,023
Cash and cash equivalents, end of period	$ 36,752	$ 124,198	$ 36,752	$ 124,198